Evidence map›Paper›PMID 31998403›Full record

ArticleChinese medicine2020

Interventional effects of the direct application of "Sanse powder" on knee osteoarthritis in rats as determined from lipidomics via UPLC-Q-Exactive Orbitrap MS.

Peng Wu, Zhengquan Huang, Jinjun Shan, Zichen Luo, Nongshan Zhang, Songjiang Yin, Cunsi Shen, Runlin Xing, Wei Mei, Yancheng Xiao and 3 more

Open access · goldAbstract read
In one paragraph

Article in Chinese medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. TRPA1-Related Diseases and Applications of Nanotherapy.International journal of molecular sciences · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Peng Wu *1Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029 China.
Zhengquan Huang *1Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029 China.
Jinjun Shan3Medical Metabolomics Center, Nanjing University of Chinese Medicine, Nanjing, 210023 China.
Zichen Luo3Medical Metabolomics Center, Nanjing University of Chinese Medicine, Nanjing, 210023 China.
Nongshan Zhang1Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029 China.
Songjiang Yin1Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029 China.
Cunsi Shen3Medical Metabolomics Center, Nanjing University of Chinese Medicine, Nanjing, 210023 China.
Runlin Xing1Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029 China.
Wei Mei1Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029 China.
Yancheng Xiao1Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029 China.
Bo Xu1Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029 China.
Jun Mao1Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029 China.
Peimin Wang1Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029 China.ORCID 0000-0003-1870-4578
Nanjing University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOur previous clinical evidence suggested that the direct application of "Sanse powder" the main ingredient of "Yiceng" might represent an alternative treatment for knee osteoarthritis. However, the mechanism underlying its effect is poorly understood. In this study, we investigated the mechanism of the effect of direct "Sanse powder" application for the treatment of knee osteoarthritis (KOA) in rats by using lipidomics.

methodsKOA rats were established by cutting the anterior cruciate ligament, and the cold pain threshold and mechanical withdrawal threshold (MWT) of seven rats from each group were measured before modelling (0 days) and at 7, 14, 21 and 28 days after modelling. Histopathological evaluation of the synovial tissue was performed by haematoxylin and eosin (H&E) staining after modelling for 28 days. Interleukin-1β (IL-1β), pro-interleukin-1β (pro-IL-1β) and tumor necrosis factor-α (TNF-α) proteins in synovial tissue were measured by western blot, and the mRNA expression levels of IL-1β and TNF-α in synovial tissue were measured using Real-time reverse transcription polymerase chain reaction (qRT-PCR), the levels of IL-1β and TNF-α in rat serum were measured by enzyme-linked immunosorbent assay (ELISA), Serum lipid profiles were obtained by using ultra-performance liquid chromatography combined with quadrupole-Exactive Orbitrap mass spectrometry (UPLC-Q-Exactive Orbitrap MS).

resultsThe results confirmed that the direct application of "Sanse powder" had a significant protective effect against KOA in rats. Treatment with "Sanse powder" not only attenuated synovial tissue inflammation but also increased the levels of the cold pain threshold and MWT. In addition, the lipidomics results showed that the levels of diacylglycerol (DAG), triacylglycerols (TAGs), lysophosphatidylcholine (LPC), phosphatidylcholine (PC), fatty acid esters of hydroxy fatty acids (FAHFAs), and phosphatidylethanolamine (PE) were restored almost to control levels following treatment.

conclusionsLipidomics provides a better understanding of the actions of direct application "Sanse powder" therapy for KOA.

Indexed as

Direct application “Sanse powder” therapyKOA lipidomicsLC–MSPrescription

Identifiers

PMID31998403
PMCPMC6979340
OpenAlexW3007827418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.